(CFU-c) devoid of CSA-producing cells and mature granulocytes, CSA-producing cells depleted of mature granulocytes and mature granulocytes alone (2, 17) . Cells were separated by a density cut in bovine serum albumin (density, 1.070 g/cm3; osmolarity, 270 mosmol). CFU-c were present in the nonadherent low density fraction (<1.070 g/cm s) and CSA-producing cells were found in the adherent low density fraction. Mature granulocytes (90-100% pure) were present in the high density fraction (>1.070 g/urnS).
Assay Procedures
A. CSA PRODUCTION. Human active CSA was obtained from endogenous marrow CSAproducing cells, peripheral blood monoeytes, and placental cells, all of human origin (2, 17, 23) . Human adherent low density blood cells which contained >90% monocytes as judged by morphological criteria and histochemical affinity for a naphtyl acetate esterase and neutral red were suspended at 2-5 × 105 cells/ml and allowed to condition McCoys medium (Memorial Sloan-Kettering Institute, N. Y.) containing 10% fetal calf serum (FCS) (Microbiological Associates, Walkersville, Md.) with CSA for 2-4 days.
Murine active CSA was obtained from medium conditioned by WEHI-3 cells, a touring myelomonocytic leukemia cell line (4, 24) , and from heart and lung of mice treated with eyclophosphamide. WEHI-3 cells were suspended at I-2 × l0 s cells/ml and allowed to condition medium as above. The entire heart was removed from each treated mouse, rinsed in McCoy's medium, sliced into six to eight large parts, and allowed to condition 5 ml of medium for 3-4 days. The intact lung from each treated mouse was also allowed to condition 5 ml of medium with CSA.
Dilutions of test material were placed in the dishes at time zero with the human monocytes or WEHI-3 cells or 1 and 2 days after the cells had started to condition the culture medium.
Human and murine cell conditioned medium were assayed for CSA as in C either undiluted or diluted at 0.1 ml before or after dialysis in spectropor membrane tubing (tool wt cutoff ~6-8,000 daltons; Spectrum Medical Industries Inc., Los Angeles) against 10 mM sodium phosphate buffer pH 7.0 (2 × 100 vol). Conditioned medium was passed through a Millipore filter (Millipore Corp., Bedford, Mass.) and stored at -20°C until assay.
B. COLONY. (>50 cells/clone) and cluster (3-50 cells/clone) formation of bone marrow CFU-c stimulated by endogenous CSA-producing cells (spontaneous assay). Human bone marrow cells depleted of mature granulocytes (density <1.070 g/cm a) and bone marrow cells of mice recovering from c~clophosphamide at a time when mature granulocytes were absent were suspended at 3 X 10 cells in 1 ml of a 0.3% agar culture medium (Difco Laboratories, Detroit, Mich.) with enriched McCoy's medium containing 10% heat-inactivated FCS. Inhibition of human colony formation was assessed by addition of 0.1 ml of various dilutions of test material.
C. COLONY AND CLUSTER FORMATION OF BONE MARROW CFU-C STIMULATED BY EXOGENOUSLY
SUPPLIED CSA. In the human assay, 1-2 X 105 nonadherent low density bone marrow cells (depleted of endogenous CSA-producing cells) per milliliter in 0.3% agar culture medium were stimulated by CSA derived from human blood leukocytes in a 0.5% agar feeder layer (prepared 3-7 days before addition of target cells and test material), or a constant amount of stimulatory activity derived from human blood monocyte or human placental cell-conditioned medium. In the mouse assay, 0.5-1.0 × 105 unseparated or nonadherent mouse bone marrow cells were stimulated by murine cell conditioned medium. Dilutions of inhibitory test material were made and 0.1 ml added to the culture plates.
D. IN vivo INHIBITORY ASSAY. 5-7-wk old conventionally outbred female Swiss mice (CD-1, Charles River Breeding Laboratories, Inc., Wilmington, Mass.) and 3-6 mo-old C57B1/6 mice (The Jackson Laboratory, Bar Harbor, Maine) were treated with 200 mg cyclophosphamide/kg body wt and served as an in vivo model for inhibition of rebound granulopoiesis as described in reference 5.
E. ERYTHROID COLONY ASSAYS. Erythroid colony assays were carried out according to the method of Iscove et al. (Friedrich Miescher-Institut, Basel, Switzerland) (25, 26) . Human unseparated or nonadherent low density bone marrow cells were plated at 1 or 2 X 105/plate and murine bone marrow cells were plated at 2 × 105/plate. Cells were plated in alpha medium containing a final concentration of 0.8% methylcellulose, 30% FCS, 1% bovine serum albumin, and 1 U/ml of human urinary erythropoietin. The erythropoietin was kindly supplied Flo. 1. Immunoelectrophoresis of normal human serum, lactoferrin, and transferrin developed against anti-transferrin and anti-laetoferrin antisera. Well a, normal human serum; well h, purified human transferrin; well e, normal human serum; well d, purified human lactoferrin (photograph of unstained preparation).
by Dr. Norman Iscove. Individual colonies were plucked, placed on glass slides, stained with benzidine, and counter stained with Wright-Giemsa to confirm the erythroid nature of the colonies.
Culture Conditions and Scoring of In Vitro Cultures.
In vitro cultures were incubated at 37°C in a humidified atmosphere of 5% CO2 in air. Myeloid colonies (>50 cells) and clusters (3-50 cells) were scored at days 7-12 for human cells and days 5-7 for mouse cells. Human erythroid colony-forming units (CFU-e) and burst-forming units (BFU-e) were scored at 7 and 14 days, respectively. Murine CFU-e and BFU-e were scored at 2 and 9 days, respectively.
Statistics. The probability of differences between samples was determined with the use of the Student's t test. Three to five plates were scored for the CFU-c assay and four to eight plates were scored for the CFU-e and BFU-e assays. In the assay for CSA production, the supernate from three to five plates was each assessed separately with three to five agar culture plates scored for each conditioned medium plate. The cells from the tissues and organs of each mouse were set up separately using five plates per point. The means :t: 1 SEM of each experimental point were obtained from the average values of five mice.
Preparation of Cell-Free Granulocyte Colony InhibitorY Factor (CIF).
Cell extracts were prepared by suspending mature granulocytes at concentrations of 1.0-20.0 × 10 n cells/ml in serum-free enriched McCoy's 5A medium and lysing the cells by rapid freezing and thawing (one to three times to 0°C). Extracts were passed through a Millipore filter (pore size, 0.45/aM). CIF was also obtained when mature granulocytes were allowed to condition serum-free medium for 1-2 days. The extracts or conditioned media were frozen and used as needed or subjected to purification by uhracentrifugation, DEAE-Sephadex chromatography, sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, and isoelectric focusing as previously described (6) .
Agents Used
ANTISERA. The purified immunoglobulin fractions of rabbit anti-human LF and transferrin (TF) were obtained from Dako Immunoglobulins (Accurate Chemical & Scientific Corp., Hicksville, N. Y.) and goat anti-human LF antiserum (27) was generously supplied by Dr. Jiri Mesteky (University of Alabama, Birmingham, Ala.). Anti-LF immunoglobulin gave a single precipitation line after immunoelectrophoresis (Fig. 1) or Ouehterlony double diffusion (not shown) against purified LF and human skim milk but did not cross-react with purified TF or normal human serum. Conversely, anti-TF immunoglobulin gave a single sharp precipitation line against purified TF or normal human serum but did not cross-react with purified LF. Mature granulocyte extracts cross-reacted with anti-LF but not anti-TF (data not shown).
Rabbit anti-human Ia antisera prepared as described in (28) Rabbit anti-human fl2-microglobulin was purchased from Dako Immunoglobulins. Rabbit anti-human IdA was purchased from Behring Diagnbstics (Somerville, N. J.), and rabbit antihuman complement (Ca) and rabbit anti-human a2-macroglobulin were purchased from N. L. Cappel Laboratories Inc., (Coehranville, Pa.). The antisera were extensively dialyzed at 4°C against phosphate-buffered salt solution (PBS) to remove previously added sodium azide before use in the in vitro tests. Commercial LF, prepared by ammonium sulphate precipitation of human skim milk (29) was obtained from Calbiochem (San Diego, Calif.). LF was purified in this laboratory from human skim milk by the method of Johannson (30) as adapted by Queringean, Masson, and Heremans (15) . Purified human TF was purchased from Behring Diagnostics.
Bacterial Lipopolysaccharide. (Salmonella typhosa W0901) (LPS) was purchased from Difco
Laboratories (Detroit, Mich.).
Iron Removal and Saturation of LF.
Apo-LF was prepared by dialysis at 4°C against 100 vol of 0.1 M citric acid (31, 32) . After 48 h, the protein was dialyzed with two changes against PBS at 4°C.
Iron-Saturated LF and TF. Iron-saturated LF and TF were prepared in two ways. In the'first method, native LF was dialyzed for 48 h at 4°C, first against 500 vol of saturated ferrous ammonium sulphate and then against PBS at 4°C (32). In the second method, 10/tl of various dilutions of a 10-mM ferric citrate solution were added to three 1-ml samples of LF or TF at 100 #g protein/ml to yield either fully saturated, partially saturated (~30-45% saturated), or poorly saturated (~8% saturated) solutions. The fully saturated LF from the first and second methods were equally potent when assayed against CSA production.
Isoelectric Focusing. Preformed polyacrylamide gel plates (245 × 110 x 1 mm) containing 2.4% wt/vol ampholytes (pH range of 3.5-9.5) were purchased from LKB (Sweden) (33) . The test materials were applied on the gel surface and the gel was focused for -~2 h after which l-cm squares were cut along the gel edge from the cathode to the anode. These were each placed in 1 ml of distilled water overnight and used to measure the pH. The remainder of the gel was cut into l-era strips each of which was further cut into 11 l-era squares. Each square was eluted overnight in 1 ml of PBS and the eluate dialyzed extensively against PBS.
Results

Comparative Analysis of the In Vitro Action of CIF and LF on Colony and Cluster Formation.
Conditioned media and extracts from human and murine mature granulocytes inhibit spontaneous colony and cluster formation of human and murine bone marrow cells by suppressing endogenous CSA production (2 
Fxo. 4. Medium conditioned by adherent mononuclear blood cells in presence ofCIF, lactoferrin, or transferrin before addition to target ceils. Inhibitory effect of lactoferrin and CIF on the elaboration of CSA from adherent mononuclear blood ceils (90% monocytes). Transferrin had no effect on CSA production.
was noted that native LF (8% iron saturated) also reduced spontaneous colony and cluster formation of human bone marrow cells. One of four similar dose-response assays is presented in Fig. 2 . Native LF maximally inhibited 71% of colonies (Fig. 2 a) and 55% of total aggregates (Fig. 2 b) . The inhibitory activity fell off but was still detectable between 10 -13 and 10 -14 M for colonies, 10 -12 and 10 -13 M for colonies and clusters, and all activity was lost by 10-a4-10 -t6 M LF.
Effect of Iron Saturation on the Action of LF. It was readily apparent from Fig. 2 and
four other experiments that the percent iron saturation of LF markedly influenced inhibitory activity. LF depleted of iron (Apo-LF) was only inhibitory at concentrations > 10 -7 M, but fully iron-saturated LF extended the dilution of LF that inhibited spontaneous colony and cluster formation (to 10 -17 M) and also increased the plateau levels of inhibition to 84% and 65% for colonies and total aggregates, respectively. As shown in Fig. 2 (and in three additional experiments not shown), human TF had minimal inhibitory activity (10-34%) at concentrations > 10 -6 M. Fully saturating TF with iron did not enhance this minimal inhibitory activity.
Site and Mode of Action of LF.
To determine the mechanism of LF action, two other assay systems were employed. In the first, endogenous CSA-producing cells were removed from low density marrow cells by adherence to plastic and the effect of LF was monitored on colony and cluster formation of nonadherent marrow cells stimulated by exogenous CSA. In the second assay, the effect of LF on CSA production was assessed.
The results of one of four similar experiments using blood leukocyte feeders as a source of exogenous CSA is shown in Fig. 3 . LF (apo to fully iron saturated) at concentrations between l0 -~ and 10 -11 M had no effect on exogenously stimulated colony and cluster formation of bone marrow cells depleted of adherent endogenous CSA-producing cells. TF at these concentrations also had no influence on the assay (data not shown). In six other experiments, I0-4-I0 -s M LF had no effect on colony and cluster formation of nonadherent bone marrow cells stimulated by various dilutions of human placenta-conditioned medium CSA (in the range of 3-150 colonies and 10-450 total aggregates). This suggested that LF was not acting to inactivate performed CSA or to decrease the sensitivity of CFU-c to CSA.
The capacity of LF to inhibit CSA production was tested by incubating LF with human adherent mononuclear blood cells. As shown in Fig. 4 , purified CIF and LF at 10 -6 and 10 -7 M suppressed CSA production, but TF at 10 -6 and 10 -7 M was without effect. Preincubation of mononuclear blood cells with 10 -7 M LF for x~ h before washing reduced CSA production to the same extent as leaving LF in the medium through the 3-day conditioning medium period. Both procedures resulted in 60% inhibition of CSA production. The suppressive effect of LF was reversible and could be blocked and/or overcome in a concentration-dependent fashion by bacterial LPS activation of human adherent mononuclear blood cells. As demonstrated in Fig.  5 , more LPS was needed to overcome the effect of increasing concentrations of LF and vice versa. 0.1 #g LPS decreased the inhibitory influence of LF but did not increase CSA production, whereas I #g of LPS both stimulated CSA production and reversed the inhibition. In another experiment, shown in Table I , in which human adherent mononuclear blood cells and murine WEHI-3 cells were exposed to 10 -s M LF at day 0 and 1 #g LPS at either day 0, 1, or 2, LPS reversed the inhibitory activity of LF. The reversal was total if LPS was added at day 0, partial if LPS was added 1 day after LF, and nil if added at 2 days. Human conditioned medium collected after 3 days and WEHI-3 conditioned medium collected after 2 days. § Significant change P < 0.05. * One part antiserum plus three parts test material were incubated at room temperature for 2-3 h before placing into test assay. The antiserum itself had no effect on the assay. :~ Colonies and clusters per 3 X 105 light density human bone marrow cells stimulated by endogenous CSA (spontaneous assay) were scored after 10 days of incubation. Results were similar for colonies. § Crude CIF is initial mature granulocyte extract and purified CIF is extract subjected to DEAE Sephadex chromatography, SDS polyacrylamide gel electrophoresis, and isoelectric focusing as in reference 6 . ]] Significant change, P < 0.05. not shown). This fraction, commercial LF, and purified CIF were subjected to isoelectric focusing and the capacities of these three materials to suppress CSA production were compared. Maximum inhibitory activity for the three preparations were found in the same area which corresponded to a pH range of 6.5 (data not shown), a pH value consistent with that determined by others for LF (14, 16 Lactoferrin, 1/~g/ml 248 ± 13 -4 * Rabbit IgG anti-human lactoferrin; the antiserum (absorbed and unabsorbed) had no effect on the assay. :~ One part antiserum (10 -1 dilution) to three parts test material were incubated for 2 h after a 2 h absorption with lactoferrin or transferrin and then assayed. § All spontaneous aggregates > 3 cells (colonies and clusters) are shown but results were similar for spontaneous colonies (>50 cells aggregate) alone. [I Crude CIF is initial mature granulocyte extract and purified CIF is extract subjected to DEAE Sephadex chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis, and isoelectric focusing as in reference 6. ¶ Significant change, P< 0.05. ** 25/zg Lactoferrin were incubated with 0.5 ml of a 1/10 dilution of anti-lactoferrin because a titer of 500 /~g/ml yields 100% absorption on the basis of Sewell test (personal communication, Dakopatts, Denmark). As a control, 25 #g transferrln was incubated with 0.5 ml of 1/10 dilution of anti-lactoferrin. When 15 #g lactoferrin were incubated with 0.5 ml of a 1/10 dilution of antiqactoferrin, it did not absorb out the effect of the anti-lactoferrin which was still able to completely inactivate the inhibitory effects of lactoferrin and CIF.
Identity of LF and CIF
Specificity Controls
EFFECT OF ANTI-LF AND OTHER NONRELATED ANTISERA. As shown in Table II , the purified immunoglobulin fraction of rabbit anti-human LF (at 10 -1 and 10 -2 dilutions) inactivated the effect of the crude and purified CIF, whereas a 10 -1 dilution of the purified immunoglohulin fraction of rabbit anti-human TF had no influence on CIF. Rabbit anti-LF also inactivated the influence of LF on CSA production (Table  III) . The influence of anti-LF on CIF was blocked by prior absorption of the anti-LF with neutralizing concentrations of LF, but TF did not block the inactivation of CIF by rabbit anti-LF. Goat anti-human LF antiserum at a 10 -a dilution inactivated the CSA inhibitory effects of 10 -s/~g LF and a 10 -2 dilution of the purified CIF, whereas a 10 -4 dilution of goat anti-LF did not inactivate 10 -6 #g LF but partially inactivated 10 -l°/zg LF (data not shown). Normal goat serum did not inactivate LF or CIF.
In further attempts to determine the specificity of inactivations, various other * None of the changes were significant, P > 0.05. PMN, polymorphonuclear neutrophils --mature granulocytes.
antisera were tested. None of the following antisera inactivated LF or CIF: antihuman Ia 1/40, anti-human fl2-microglobulin (10-x), anti-human az-macroglobulin (10-1), anti-human IgA (10 -1) and anti-human complement (Ca) (10-1).
EFFECT OF ANTI-LF ON OTHER INHIBITORS OF CFU-C WHICH DO NOT SUPPRESS CSA PRODUCTION. In further specificity tests, rabbit anti-LF had no influence on inhibitory activities which can be distinguished from CIF by their cells of derivation and action. One, termed leukemia-associated inhibitory activity (LIA), is derived from leukemic bone marrow and blood cells and inhibits colony formation by normal CFU-c but not leukemic CFU-c (34, 35) . The other, neutropenia-associated inhibitory activity (NIA), is derived from bone marrow and blood cells of patients with neutropenia of varying etiologies and inhibits colony formation of normal, leukemic and neutropenic CFU-c (36). LIA and NIA do not influence CSA production (34, 36) .
EFFECT OF LF AND CIF ON ERYTHROID COLONY FORMATION. CIF, LF, and intact mature granulocytes were assayed for their influence on erythropoietin-dependent CFU-e and BFU-e cells. As shown in Table IV , CFU-e and BFU-e from human marrow and BDF and C57B1/6 mouse marrow were not inhibited. These results have been repeated on three other human marrow samples and one other mouse sample.
EFFECT OF LF ON MURINE REBOUND GRANULOPOIESIS AND CSA PRODUCTION IN VlVO. Having demonstrated that LF was identical to CIF in its in vitro action, it was important to substantiate this finding in vivo. Thus, a recently published in vivo assay which depends on rebound granulopoiesis to detect inhibition by administered § Percent significant change (P < 0.05) from media control.
CIF (5) was utilized to test the in vivo effect of LF. Three days after i.p. injection of 200 mg cyclophosphamide/kg body wt, mature granuloeytes are depleted from mice whereas absolute numbers of CFU-c and net endogenous CSA production are increased in the bone marrow (5) . Administration of 20 #g human LF during the 1st and 2nd days after cyclophosphamide dampened rebound granulopoiesis in the marrows of CDx and C57B1/6 mice as assessed on the 3rd day after cyclophosphamide (Table V) . LF substantially decreased total marrow CFU-c numbers as detected by adding a source of exogenous CSA to the marrow cells in culture. Inhibition of marrow CFU-e numbers was more pronounced in CD1 (80%) than in C57B1/6 mice (42%). Net endogenous marrow CSA production, as demonstrated in cultures without exogenously added CSA, was also substantially reduced. 20 #g of TF did not have a significant influence in these assays. Heart and lung cells removed from both mouse strains injected with LF produced 65-86% less CSA than control mice injected with McCoy's media or TF (Table VI) . This was substantiated by assaying dialyzed as well as undialyzed conditioned media. Discussion It has been suspected that LF might have activities in addition to its capacity to act as a bacteriostatic agent (37) . We have now presented evidence indicating that LF is identical to CIF and as such has the additional capacity to regulate CSA production in vitro and granulopoiesis in vivo.
Three experimental approaches were used to identify LF as the granulocyte CIF: the first was to demonstrate that LF acted in vitro and in vivo in a manner analogous to CIF; the second was to demonstrate that the inhibitory activity was localized in the same region after separation of LF and CIF by isoelectric focusing; and the third was to demonstrate that anti-LF antisera could inactivate the action of both CIF and LF.
LF, as reported earlier for CIF (2) , and as documented here, inhibits CSA production by interacting with monocytes and marcrophages but does not decrease the sensitivity of the granulocyte progenitor cells (CFU-c) to CSA nor does it inactivate CSA. Significant inhibition of CSA production was attained by 10 -1. M native LF (8% iron saturated). This effect was dependent on the iron saturation of LF molecules. Apo-LF was only minimally active at concentrations >10 -6 M whereas fully ironsaturated LF samples were active at 10-17-M concentrations. The greater inhibitory activity noted with increased iron saturation of LF probably reflects further binding of lactoferrin to monocytes and macrophages. The capacity of LF to bind to macrophages is enhanced by iron saturation of the molecules (21, 22) , a phenomenon believed to result from a conformational change of the protein upon iron binding (16, 21) . Failure to reduce CSA production to zero levels is most likely related to the fact that monocytes and macrophages contain performed CSA (2) and that already formed but not yet released CSA is not affected by LF. The inhibitory effect of LF was fully reversed by bacterial LPS if LPS was added simultaneously with the LF, and partially reversed if LPS was added 24 h after LF. The mechanisms of these interactions are not clear but may relate to the iron-binding capacity of LPS (38, 39) because it has been reported that 1 mg LPS binds 4.8-5.2/~g of iron (38) . It has been postulated that mature granulocytes limit CSA production by eliminating bacteria (40) , however, mature granulocytes in the presence of bacterial products and in response to phagocytic challenge release large quantities of their intracellular contents of LF (22, 41) and suppression of CSA production in these circumstances is probably mediated via LF.
The interesting correlation between iron content and activity illustrates how one molecule can have two distinct but closely related functions. LF has bacteriostatic and bacteriocidal activity only in the apo or native form (32, (42) (43) (44) (45) (46) whereas fully saturated LF is most effective and apo-LF is least effective in suppressing CSA production. Each mature granulocyte (polymorphonuclear neutrophil) contains 3-6 pg of LF (14, (47) (48) (49) ; this implies that there is enough LF in one mature granulocyte to inhibit CSA production of >200,000 monocytes by >60%. If, as suggested earlier, neutrophils act as exocrine cells (50) a regulatory mechanism of granulopoiesis can be envisaged as follows: native LF contained in the secondary granules of mature granulocytes (47, 51) leaves the cell, possibly in response to specific stimuli; and with an iron association constant of 3 × 10 z8 (16) binds iron from the serum, thus facilitating its capacity to bind to specific receptor sites on monocytes and macrophages. This then results in greater suppression of CSA production. It has been calculated that milligram quantities of LF are produced per day by granulocytes (52) . This figure, added to the specific activity of LF in vitro and the microgram quantities needed for in vivo activity argue strongly for a physiological role for LF in the regulation of granulopoiesis.
Further studies of the mechanisms involved in this regulatory process are in progress. The identification of CIF as LF allows for more detailed studies in vitro and in vivo using purified and labeled molecules. With these molecules it will be possible to characterize the postulated role of LF in cell traffic (7, 8) . In addition, it will now be possible to define more precisely the nature of feedback abnormalities associated with myelogenous leukemia and myelodysplasia. We have shown that CSA-producing cells of patients with chronic myelogenous leukemia are less responsive than normal to suppression by CIF (3). This phenomenon which may relate to the iron-binding capacity of patient LF or to altered or deficient LF-membrane receptors on patient monocytes and macrophages is under investigation. Summary Lactoferrin (LF), the iron-binding protein present in the specific granules of mature granulocytes has been identified as colony inhibitory factor (CIF) which suppresses granulocyte--macrophage colony stimulating activity (CSA) production by monocytes and macrophages in vitro and rebound granulopoiesis in vivo. Separation of LF and CIF by isoelectric focusing confirmed that the regions of inhibitory activity corresponded in both to a pH of ---6.5. In addition, the purified immunoglobulin fraction of rabbit anti-human LF antiserum, but not rabbit anti-transferrin (TF), inactivated the capacity of LF and CIF to inhibit CSA production, an effect blocked by prior incubation of anti-LF with neutralizing concentrations of LF. Suppression of CSA production correlated with the iron-saturation of LF; apo-LF (depleted of iron) was only active at concentrations >10 -7 M, native LF (8% iron saturated) was active at 10 -Is M, and fully iron-saturated LF inhibited at 10 -17 M. Suppression of CSA production occurred within a 1/2-h preincubation period with human blood monocytes but was reversed by bacterial lipopolysaccharide (LPS). This reversal was dependent on the relative concentrations of LF to LPS. Serum TF, a biochemically similar ironbinding protein which is antigenically distinct from LF, was only minimally active at concentrations >10 -6 M. LF did not inhibit exogenously stimulated human granulocyte and macrophage colony-forming cells or erythropoietin-dependent human or murine erythroid colony-or erythroid burst-forming cells. Microgram quantities of LF acted in vivo to inhibit rebound granulopoiesis and CSA production in CDx and
